Stanley-Laman Group’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.8M Sell
63,297
-332
-0.5% -$104K 2.27% 3
2026
Q2
$27.6M Sell
63,629
-2,289
-3% -$695K 2.8% 1
2026
Q1
$14.1M Buy
65,918
+533
+0.8% +$119K 1.73% 5
2025
Q4
$11.2M Sell
65,385
-252
-0.4% -$39.2K 1.42% 8
2025
Q3
$8.79M Buy
+65,637
New +$6.95M 1.25% 12
2021
Q3
– Sell
-9,070
Closed -$590K – 266
2021
Q2
$590K Hold
9,070
– – 0.08% 206
2021
Q1
$540K Buy
+9,070
New +$494K 0.09% 208

Other funds holding LRCX

Stanley-Laman Group's LRCX Position: Q3 2026 in Review

Stanley-Laman Group reduced its Lam Research (LRCX) stake by 0.52% in Q3 2026, selling an estimated $104K and leaving 63,297 shares worth $20.8M. The position accounts for 2.27% of the portfolio, ranked #3.

Stanley-Laman Group first reported a position in LRCX in Q1 2021 and has held it in 7 quarters since. The position peaked at $27.6M in Q2 2026. 1,014 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Stanley-Laman Group held 63,297 shares of Lam Research worth $20.8M as of Q3 2026.
  • Stanley-Laman Group sold 332 Lam Research shares in Q3 2026, an estimated $104K.
  • Lam Research made up 2.27% of Stanley-Laman Group's portfolio in Q3 2026, its #3 holding.
  • Stanley-Laman Group first reported a position in Lam Research in Q1 2021 and has held it in 7 quarters since.
  • Stanley-Laman Group's Lam Research position peaked at $27.6M in Q2 2026.
  • 1,014 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Stanley-Laman Group's 13F filing for Q3 2026, filed 20 Oct 2026.